Key Insights

Highlights

Success Rate

97% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.5%

1 terminated out of 65 trials

Success Rate

97.1%

+10.6% vs benchmark

Late-Stage Pipeline

5%

3 trials in Phase 3/4

Results Transparency

0%

0 of 34 completed with results

Key Signals

97% success

Data Visualizations

Phase Distribution

46Total
Not Applicable (40)
Early P 1 (1)
P 2 (2)
P 4 (3)

Trial Status

Completed34
Unknown19
Recruiting6
Not Yet Recruiting2
Enrolling By Invitation2
Terminated1

Trial Success Rate

97.1%

Benchmark: 86.5%

Based on 34 completed trials

Clinical Trials (65)

Showing 20 of 20 trials
NCT06433284Not ApplicableEnrolling By InvitationPrimary

Comparative Study of Decellularized Human Amniotic Membrane Hydrogel and Inverted Internal Limiting Membrane Flap in Idiopathic Large Macular Holes

NCT07228091Recruiting

Surgical Procedure Efficiency Evaluation stuDy

NCT03713268RecruitingPrimary

Intraoperative OCT Guidance of Intraocular Surgery II

NCT04904679Not ApplicableActive Not RecruitingPrimary

The Use of Amniotic Membrane or Internal Limiting Membrane for Large or Refractory Macular Holes: A Prospective Study

NCT06927544Not ApplicableEnrolling By Invitation

Intraocular Gas Tamponade for Treatment of Large Idiopathic Macular Holes

NCT06915948CompletedPrimary

Postoperative Same Day Closure of Giant Macular Hole With Silicone Oil

NCT06536569Phase 4Not Yet RecruitingPrimary

Comparison of Efficacy Between ILM Forceps

NCT06000111Not ApplicableRecruitingPrimary

Duration of Face Down Positioning for Full-Thickness Macular Hole Repair

NCT06211907Not ApplicableRecruitingPrimary

Small Macular Holes Treated With Air

NCT05860985Not ApplicableCompleted

Zeiss RESIGHT Disposable Lenses Evaluation Study

NCT06560710CompletedPrimary

Clinical Characteristics and Surgical Outcomes of Full-thickness Macular Hole Without Focal Vitreomacular Traction.

NCT06359548Not ApplicableRecruitingPrimary

PEELED INTERNAL LIMITING MEMBRANE REPOSITION

NCT06323902CompletedPrimary

Autologous Platelet-rich Plasma as a Treatment for Macular Holes

NCT05747144RecruitingPrimary

Multimodal Imaging in Vitreo-retinal Surgery and Macular Dystrophies

NCT06233500Not ApplicableUnknownPrimary

Macular Micro Vascular Changes Following Macular Hole Repair : Optical Coherence Tomography Angiography Study

NCT06200727Not ApplicableUnknown

Platelet-rich Fibrin(PRF) Membrane in Ophthalmic Diseases

NCT06079593Not ApplicableNot Yet RecruitingPrimary

GaslEss Macular Hole Surgery

NCT04676217Not ApplicableCompletedPrimary

Position Related Changes in Macular Hole Morphology Before and After Surgery

NCT06115005Phase 2UnknownPrimary

Treatment of Challenging Macular Holes Using Plasma Rich in Growth Factors

NCT06063005Not ApplicableUnknownPrimary

Clinical Study of Translocated Internal Limiting Membrane Flap Reposition for the Treatment of Idiopathic Macular Hole

Scroll to load more

Research Network

Activity Timeline